olivlawolivlaw

olivLaw · European equity research

APLISENS Spółka Akcyjna APN.WA

Poland · GPW Warszawa · ISIN PLAPLS000016 · Vertical: Listed companies from Poland

17.80PLN−1.11% · 1 dayClose 05 Nov 2026

APLISENS is a Polish group producing measurement transmitters and systems for industry. Its 2022 annual report shows solid equity but a significant share of sales in foreign currencies, which makes exposure to exchange rates relevant. The analysis rests solely on the consolidated 2022 annual report provided.

At the close of 05 Nov 2026, APLISENS Spółka Akcyjna (APN.WA) stock was 17.80 PLN (−1.11% on the day), with market capitalisation 194.6 m PLN, P/E 9.5 on diluted EPS of 1.87 PLN over the last 12 months, dividend yield 3.60%, beta 0.25, 52-week range 16.80–21.00 PLN.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
194.6 m PLN
shares as of 31 Dec 2022
P/E (TTM)
9.5
Diluted EPS TTM 1.87 · TTM to 31 Dec 2022
E/P (TTM)
10.51%
TTM to 31 Dec 2022
Dividend yield
3.60%
DPS 12m 0.64
Beta (2y)
0.25
Volatility (1y) 23%
52-week range
16.8021.00

Price history

Loading chart…

Technical reading

RSI (14)
34.1
weak (30–45)
Bollinger (20, 2)
16.92 – 20.00
in the lower half of the band · %B 0.29 · band width 16.7%
SMA 50 / 200
19.43 / 18.47
mixed trend
MACD (12, 26, 9)
-0.45 / -0.46
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month−7.3%+0.4%−7.7 pp—
3 months−13.2%−3.3%−9.9 pp—
6 months−3.8%+4.0%−7.7 pp—
Year to date+4.4%+8.1%−3.7 pp—
1 year−2.7%+10.7%−13.4 pp+7.5%
3 years−19.1%+50.1%−69.2 pp+4.2%
5 years+29.0%+43.6%−14.6 pp—
Max drawdown (1y)
−15.7%
03 Aug 2026 → 23 Oct 2026
Max drawdown (5y)
−35.1%
24 May 2024 → 24 Feb 2026
Compound annual growth (5y)
+5.2%
EURO STOXX 50 +7.5%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 100 percentile of its own 3-quarter history (min 7.5, median 8.8, max 9.1; quarters with earnings only).

Fiscal years

Fiscal year202020212022
Revenue108.0 m121.4 m147.8 m
Revenue YoYunavailable+12.4%+21.8%
Net income14.5 m17.2 m20.4 m
Net income YoYunavailable+19.0%+18.8%
Diluted EPS1.261.541.87
Diluted EPS YoYunavailable+22.2%+21.4%
net %13.4%14.2%13.8%
Free cash flowunavailableunavailableunavailable

Balance sheet & financial health

Fiscal year 2022 · 31 Dec 2022

Cash
13.6 m PLN
Financial debt
unavailable PLN
Net debt
unavailable PLN
Equity
186.2 m PLN
Total assets
202.4 m PLN
Debt / equity
unavailable
Current ratio
7.09x
ROE
11.1%
ROA
10.3%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (PLN)

Margins

Income statement · PLN

Revenue
2020
108.0 m
2021
121.4 m
2022
147.8 m

esef· 02 May 2023verified

Cost of revenue
2020
72.6 m
2021
77.6 m
2022
89.1 m

esef· 02 May 2023verified

Gross profit
2020
35.4 m
2021
43.8 m
2022
58.8 m

esef· 02 May 2023verified

Operating income
2020
17.4 m
2021
21.6 m
2022
26.0 m

esef· 02 May 2023verified

Interest expense
2020
13.0 k
2021
473.0 k
2022
332.0 k

esef· 02 May 2023verified

Pre-tax income
2020
17.5 m
2021
21.3 m
2022
25.9 m

esef· 02 May 2023verified

Income tax
2020
2.6 m
2021
3.3 m
2022
5.1 m

esef· 02 May 2023verified

Net income
2020
14.5 m
2021
17.2 m
2022
20.4 m

esef· 02 May 2023verified

Diluted EPS
2020
1.26
2021
1.54
2022
1.87

esef· 02 May 2023verified

Dividend per share
2020
0.26
2021
0.60
2022
0.64

esef· 02 May 2023derived

Balance sheet · PLN

Cash
2020
12.5 m
2021
10.0 m
2022
13.6 m

esef· 02 May 2023verified

Receivables
2020
13.8 m
2021
20.4 m
2022
23.2 m

esef· 02 May 2023verified

Inventories
2020
38.8 m
2021
43.2 m
2022
59.1 m

esef· 02 May 2023verified

Current assets
2020
80.4 m
2021
92.3 m
2022
105.8 m

esef· 02 May 2023verified

Property, plant & equipment, net
2020
82.1 m
2021
79.8 m
2022
76.6 m

esef· 02 May 2023verified

Goodwill
2020
2.9 m
2021
2.9 m
2022
2.9 m

esef· 02 May 2023verified

Intangibles (excl. goodwill)
2020
11.0 m
2021
12.2 m
2022
13.2 m

esef· 02 May 2023verified

Total assets
2020
182.7 m
2021
192.6 m
2022
202.4 m

esef· 02 May 2023verified

Current liabilities
2020
8.0 m
2021
10.5 m
2022
14.9 m

esef· 02 May 2023verified

Total liabilities
2020
9.4 m
2021
11.9 m
2022
16.2 m

esef· 02 May 2023verified

Equity
2020
173.3 m
2021
180.7 m
2022
186.2 m

esef· 02 May 2023verified

Shares outstanding at year end
2020
11.5 m
2021
11.2 m
2022
10.9 m

esef· 02 May 2023derived

Cash flow · PLN

Operating cash flow
2020
25.3 m
2021
20.9 m
2022
22.1 m

esef· 02 May 2023verified

Investing cash flow
2020
-19.1 m
2021
-9.7 m
2022
-948.0 k

esef· 02 May 2023verified

Financing cash flow
2020
-2.8 m
2021
-13.7 m
2022
-17.6 m

esef· 02 May 2023verified

Dividends paid
2020
3.0 m
2021
5.3 m
2022
7.0 m

esef· 02 May 2023verified

Share repurchases
2020
3.0 m
2021
9.2 m
2022
12.0 m

esef· 02 May 2023verified

Computed indicators

Growth

Revenue growth (YoY)
21.8%
computed by olivLawFY 2022
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
20.4%
computed by olivLawFY 2022
Net income growth (YoY)
18.8%
computed by olivLawFY 2022
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
21.4%
computed by olivLawFY 2022
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
input data missing

Profitability

Gross margin
39.8%
computed by olivLawFY 2022
EBITDA margin
unavailable
input data missing
EBIT margin
17.6%
computed by olivLawFY 2022
Net margin
13.8%
computed by olivLawFY 2022
FCF margin
unavailable
input data missing

Returns

ROE
11.4%
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
ROA
10.3%
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
ROIC
unavailable
input data missing
ROCE
13.9%
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
Payout ratio (EPS)
34.3%
computed by olivLawFY 2022
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
78.4x
computed by olivLawFY 2022

Liquidity

Current ratio
7.1x
computed by olivLawbalance sheet at 31 Dec 2022
Quick ratio
3.1x
computed by olivLawbalance sheet at 31 Dec 2022
Cash ratio
0.9x
computed by olivLawbalance sheet at 31 Dec 2022

Cash

Operating cash flow
22.1 m PLN
computed by olivLawFY 2022
Capital expenditure
unavailable
input data missing
Free cash flow
unavailable
input data missing
FCF conversion
unavailable
input data missing
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
54 days
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
Days inventory outstanding
210 days
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
194.6 m PLN
computed by olivLawbalance sheet at 31 Dec 2022
Enterprise value
unavailable
input data missing
Market cap / net income TTM
9.5x
computed by olivLawFY 2022
P/E (TTM)
9.5x
computed by olivLawFY 2022
Earnings yield
10.5%
computed by olivLawFY 2022
P/B
1.1x
computed by olivLawbalance sheet at 31 Dec 2022
P/S
1.3x
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
3.6%
computed by olivLawFY 2022
Shareholder yield (distributions)
9.8%
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 5 of at least 6
  • score weight coverage: 33.3% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

17.80 PLN

05 Nov 2026Source: olivLaw, closing series

Market cap: 194.6 m PLN

Key indicators

Market capitalisation
194.6 m PLN
computed by olivLawbalance sheet at 31 Dec 2022
P/E (TTM)
9.5x
computed by olivLawFY 2022
P/B
1.1x
computed by olivLawbalance sheet at 31 Dec 2022
EV/EBITDA
unavailable
input data missing
ROE
11.4%
computed by olivLawFY 2022 · balance sheet at 31 Dec 2022
Net margin
13.8%
computed by olivLawFY 2022
Revenue growth (YoY)
21.8%
computed by olivLawFY 2022
Dividend yield
3.6%
computed by olivLawFY 2022

Coverage and freshness

27/37 reporting lines present
Latest full fiscal year: 2022
Latest reported period: 31 Dec 2022
Latest balance sheet date: 31 Dec 2022
Share count (cover of the latest filing), as of: 31 Dec 2022
Source: esefpublished 02 May 2023
verified 89derived 5

The data is older than the freshness threshold.

Score by group

33% · Insufficient data

Estimated value range

unavailable — no valuation assumptions for the reporting currency

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

    Assumptions (illustrative, editorial)

    Risk-free rate
    6.5%
    Equity risk premium
    6.0%
    Beta (default)
    1.00
    Cost of equity
    12.5%
    Terminal growth
    3.0%

    Factor scorecard

    Insufficient data

    Minimum-evidence gate: indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%

    FactorValueScoreWeight used
    ROIC · Qualityunavailableunavailable—
    Net margin · Quality13.8%82 (vs peers)19%
    FCF conversion · Qualityunavailableunavailable—
    Revenue CAGR 3Y · Growthunavailableunavailable—
    EPS CAGR 3Y · Growthunavailableunavailable—
    Net debt / EBITDA · Balance sheetunavailableunavailable—
    Interest coverage · Balance sheet78.4x100 (on a fixed band)19%
    Current ratio · Balance sheet7.1x100 (on a fixed band)13%
    P/E (TTM) · Valuation9.5x63 (vs peers)31%
    EV/EBITDA · Valuationunavailableunavailable—
    FCF yield · Valuationunavailableunavailable—
    Shareholder yield (distributions) · Returns9.8%100 (on a fixed band)19%
    Payout ratio (FCF) · Returnsunavailableunavailable—

    Factors without a value were dropped; the remaining weights were renormalised.

    Score groups

    • Balance sheet100/100 · 2/3 factors with a value
    • Growth· partialunavailable · 0/2 factors with a value
    • Quality· partial82/100 · 1/3 factors with a value
    • Returns· partial100/100 · 1/2 factors with a value
    • Valuation· partial63/100 · 1/3 factors with a value

    A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

    Memo

    APLISENS Spółka Akcyjna (APN.WA). Latest full fiscal year: 2022; data up to 2022-12-31.

    Figures computed from the financial statements: revenue 147.8 m PLN in 2022; YoY growth 21.8%; net margin 13.8%; ROE 11.4%.

    The estimated value range is 9.10–22.43 PLN per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 14.81 PLN, the price of 17.80 PLN leaves a potential of -16.8% (value / price − 1) and a margin of safety of -20.2% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

    Insufficient data for a verdict (indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%).

    Text generated deterministically from the figures shown; no language model. Not investment advice.

    What supports the thesis

    • Net margin: 13.8%
    • Interest coverage: 78.4x
    • Current ratio: 7.1x
    • Shareholder yield (distributions): 9.8%

    What contradicts it

    • The valuation methods diverge

    Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, FCF yield, Payout ratio (FCF).

    Versus the vertical median

    Listed companies from Poland · same country · compared with 39 companies

    Multiples and returns vs the median

    P/E
    9.5x
    vertical median 16.8x
    below median (−43.4%)
    EV/EBITDA
    —
    vertical median —
    P/S
    1.3x
    vertical median 1.1x
    above median (+19.3%)
    P/B
    1.1x
    vertical median 1.0x
    above median (+8.9%)
    ROE
    11.4%
    vertical median 8.9%
    above median (+27.4%)
    Net margin
    13.8%
    vertical median 2.8%
    above median (+390.3%)
    EBIT margin
    17.6%
    vertical median 5.7%
    above median (+206.7%)
    Revenue YoY
    21.8%
    vertical median 9.9%
    above median (+120.8%)
    Net debt/EBITDA
    —
    vertical median —
    Dividend yield
    3.6%
    vertical median 2.1%
    above median (+71.9%)

    Price rebased to 100 (monthly, 5 years)

    Companies in the vertical

    Market capP/EROENet marginRevenue YoY1A / 3A
    BDX.WABudimex Spółka Akcyjna19.3 bn36.141.5%6.2%+8.9%+21% / +36%
    ACP.WAAsseco Poland S.A.19.2 bn38.17.8%2.9%+19.8%+19% / +202%
    BFT.WABenefit Systems Spółka Akcyjna18.1 bn131.120.8%7.2%+99.9%+74% / +221%
    CAR.WAInter Cars Spółka Akcyjna14.8 bn21.217.0%3.9%+18.0%+86% / +79%
    ASE.WAAsseco South Eastern Europe Spółka Akcyjna3.7 bn19.818.1%12.0%+36.5%+7% / +52%
    1AT.WAAtal Spółka Akcyjna2.3 bn6.429.8%22.2%−1.3%+7% / +8%
    ATT.WAGrupa Azoty Spółka Akcyjna1.7 bn—-37.9%-20.8%−45.1%−10% / −22%
    ARH.WAArchicom Spółka Akcyjna1.3 bn12.115.9%22.1%−21.6%+13% / +89%
    ACT.WAAction S.A.997.4 m27.18.3%1.5%+6.1%+70% / +170%
    BRS.WABoryszew Spółka Akcyjna889.2 m8.36.3%1.6%+8.4%−24% / −26%
    AGO.WAAgora Spółka Akcyjna601.9 m—-14.2%-9.2%+15.2%+40% / +21%
    AMB.WAAmbra S.A.468.0 m7.616.4%7.0%+12.9%+5% / −33%
    ATC.WAArctic Paper Spółka Akcyjna357.2 m1.416.3%7.0%−27.5%−38% / −75%
    ATG.WA"atm Grupa Spółka Akcyjna"299.3 m11.18.9%11.6%−22.0%−11% / +3%
    ART.WAArtifex Mundi S.A.226.6 m17.435.7%33.3%+51.9%+46% / +12%
    APN.WAAPLISENS Spółka Akcyjna194.6 m9.511.4%13.8%+21.8%−1% / −21%
    BMC.WABumech Spółka Akcyjna155.7 m—-3.4%-3.9%−40.0%−37% / −49%
    ALI.WAALTUS Spolka Akcyjna153.9 m16.87.9%16.9%+30.3%+34% / +48%
    BBT.WABoomBit Spółka Akcyjna71.4 m4.520.7%6.4%−16.5%−19% / −57%
    BBD.WABbi Development S.A.54.1 m1.136.0%208.3%+50.2%+1% / +9%
    ALG.WAAll in! Games Spółka Akcyjna39.8 m——-156.9%−72.2%−27% / −56%
    BMX.WABioMaxima Spółka Akcyjna37.0 m63.21.2%1.3%−67.5%−29% / −45%
    06N.WAMagna Polonia Spółka Akcyjna31.3 m0.5115.4%964.7%+13.0%−28% / −42%
    BCM.WABETACOM Spółka Akcyjna26.7 m17.68.0%0.9%+21.3%+8% / +4%
    AWM.WAAirway Medix Spółka Akcyjna14.3 m—-25.8%-117,400.0%−97.7%−23% / −43%

    1- and 3-year price returns: for APN.WA from daily closes (the same as the performance table), for the other companies from month-end closes.

    olivLaw engine forecast

    The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

    The engine has no published run for this company yet.

    Valuation scenarios (editable assumptions)

    Illustrative scenarios

    Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

    Bear
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Base
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Bull
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Nothing is saved.

    Estimated price (PLN)

    Estimated priceBearBaseBull
    1 years
    11.63
    Total return -32% · Per year -32%
    20.47
    Total return 19% · Per year 19%
    30.71
    Total return 77% · Per year 77%
    3 years
    13.80
    Total return -12% · Per year -4%
    27.07
    Total return 66% · Per year 19%
    44.22
    Total return 166% · Per year 39%
    5 years
    16.37
    Total return 11% · Per year 2%
    35.80
    Total return 129% · Per year 18%
    63.67
    Total return 295% · Per year 32%
    What moves the 3-year price the most
    • Exit P/E± 6.77
    • Net margin± 4.74
    • Annual revenue growth± 3.53
    • Annual dilution± 0.40

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    APLISENS is a Polish group producing measurement transmitters and systems for industry. Its 2022 annual report shows solid equity but a significant share of sales in foreign currencies, which makes exposure to exchange rates relevant. The analysis rests solely on the consolidated 2022 annual report provided.

    SWOT

    Strengths

    • High equity relative to liabilities and a low level of bank borrowing, according to the consolidated balance sheet.
    • Positive operating cash flows that support investment and dividend distributions to shareholders.
    • A programme of own-share buybacks that reflects willingness to return capital to shareholders.

    Weaknesses

    • Reliance on foreign-currency sales exposes the group to exchange rate swings against its reporting currency.
    • The inventory build tied up significant cash and may point to slower turnover of current assets.
    • The source provides no breakdown of revenue by product or region, which limits assessment of diversification.

    Opportunities

    • Investment in fixed assets could support expanded production capacity if industrial demand grows.
    • Solid equity could allow project funding without substantial reliance on debt.
    • Export markets could offer growth if the group manages its currency exposure effectively.

    Threats

    • Adverse exchange rate moves could reduce the zloty value of export revenues.
    • A slowdown in industrial investment could weaken demand for the group's instruments.
    • Geopolitical tensions, including the conflict in Ukraine noted in the report, could disrupt supply chains and markets.

    Risks

    • Currency riskhigh

      Sales and costs in currencies other than the reporting currency create exposure to exchange rates, affecting financial results.

    • Inventory riskmedium

      Higher inventories could lead to write-downs or excessive cash being tied up if demand falls.

    • Customer credit riskmedium

      One intermediary customer holds a significant share of trade receivables, concentrating exposure to non-payment.

    • Liquidity risklow

      Short-term payment obligations could become pressing if collections from customers are delayed.

    • Geopolitical riskmedium

      The conflict in Ukraine is cited as a risk the management has assessed, with possible effects on markets and supply.

    Investment thesis

    What would need to be true (bull case)

    • If positive operating cash flows persist, the group could fund investment and shareholder distributions without weakening its balance sheet.
    • High equity could provide room for manoeuvre during periods of economic uncertainty.
    • Consistent investment in fixed assets could support higher productive capacity in coming years.

    What would break the thesis

    • If exchange rates move unfavourably, export revenues could fall in zloty terms and weigh on results.
    • Rising inventories could signal weaker demand than expected, with a risk of write-downs.
    • Concentration of receivables at one intermediary could expose the group to losses if that counterparty runs into difficulty.

    What to watch

    • Inventory trends and current asset turnover2023
    • Foreign-currency exposure and the share of non-zloty sales2023
    • Receivables owed by the main intermediary customernext annual report
    • Continuation of the own-share buyback programme2023

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    According to the consolidated annual report for fiscal 2022, the APLISENS group is engaged in manufacturing and selling measuring instruments, and total group assets reached 202,411 thousand PLN at 31.12.2022 1. Equity attributable to shareholders of the parent was 182,471 thousand PLN at the same date, and the group's total comprehensive income was 20,491 thousand PLN in 2022 1. The source does not detail products or markets fully, so this description remains limited to the consolidated financial data.

    Segments

    Operations and inventories

    Inventories rose sharply in 2022, while operating cash flow stayed positive at 22,059 thousand PLN 1. The inventory build absorbed cash, indicating a rise in current assets during the year.

    Market context

    The source does not describe the size of the industrial measurement market or the group's market share. The financial data does show that around 48.6% of sales are denominated in currencies other than the reporting currency, tying export performance to exchange rates 1.

    Competitive position

    • Competitors not named in source

      The annual report supplied does not name competitors, so no specific issuers can be identified from this source.

    • European transmitter manufacturers

      General category of competitors in industrial measurement instruments, not named individually in the source.

    • Global instrumentation suppliers

      Larger competitors that could contest the same industrial segments, with no detail in the source.

    • Regional manufacturers in Central Europe

      Local competitors that could influence pricing in the Polish domestic market, not specified in the document.

    News & filings

    In the press

    No news in our archive over the last 180 days.

    Annual reports (ESEF)

    Sources

    1. [1] Annual report, fiscal year ended 2022-12-31 (ESEF) · SEC / APLISENS Spółka Akcyjna · 31 Dec 2022

    Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.